|« Previous month||Next month »|
28-Feb-2013 - Cedarburg Hauser says US CDMOs are focusing on “niche fields” in order to gain a competitive advantage on foreign competition.
28-Feb-2013 - Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry.
28-Feb-2013 - Profectus BioSciences has signed up San Diego-based CMO Althea Technologies to manufacture DNA vaccines after its deal with Boehringer Ingelheim ended due to currency issues.
28-Feb-2013 - Industry groups BIO and PhRMA are airing their discontents about US FDA draft guidance that could force sponsors to submit redundant clinical datasets for each trial site and waste time...
27-Feb-2013 - CRO Covance is teaming up with M2Gen’s cancer-focused database to increase its ability to match more patients in oncology trials based on their tumour profiles.
27-Feb-2013 - A South African and Lonza joint project says issues in funding, competitiveness and green technologies have delayed construction of its API plant.
27-Feb-2013 - Albemarle is adding new capacity at its manufacturing facility in Pennsylvania with a $30 million expansion.
27-Feb-2013 - Hospira has announced it is voluntarily recalling multiple lots of five different injections because of customer reports of faulty packaging and contamination.
26-Feb-2013 - GVK Biosciences says it is looking to target Taiwanese clients following a distribution deal with GGA over its clinical databases.
26-Feb-2013 - Eurofins, Illumina and McKesson have gone shopping and are showing off their new purchases – welcome to Outsourcing-Pharma.com’s acquisition round-up.
26-Feb-2013 - Ireland-based CRO Icon unveiled higher than expected revenue and backlog increases in 2012 when compared to 2011, and the company expects even stronger results in 2013.
25-Feb-2013 - West Pharmaceuticals says it is still intent on shifting to proprietary products following results from its packaging and contract manufacturing businesses.
25-Feb-2013 - Biopharmaceutical CMOs have seen their business slowly shrink as companies seek less volume and smaller batches, but outsourcing is expected to increase over the next three years.
25-Feb-2013 - Bend Research has partnered with its second chemistry major in six months, teaming up with BASF to develop bioavailability-boosting excipients.
25-Feb-2013 - Recipharm says taking on a contract started by another CMO is an exercise in building trust and gathering information as rapidly as possible.
21-Feb-2013 - Lonza has won a second US NIH contract to manufacture stem cells for medical research.
21-Feb-2013 - CiToxLAB says strong revenue growth in 2012 was due to a new global status following its acquisition of Lab Research.
21-Feb-2013 - Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry.
21-Feb-2013 - UK CMO Aesica claims its partnership with process innovation group Britest has already increased capacity without capital investment.
20-Feb-2013 - CMO ProBioGen says its GlymaxX ADCC antibody enhancement technology can be adapted to any biomanufacturing cell line and will attract both Big and Small Pharma.
20-Feb-2013 - CMOs (contract manufacturing organizations) developing pharmaceutical intermediates have shifted their focus to complex nucleosides, peptides and carbohydrates over the last five years, an expert says.
20-Feb-2013 - Almac says its newly approved laboratory will support US commercial launch of two new products.
19-Feb-2013 - Baxter says there is a trend towards outsourcing for cytotoxic manufacturing as it begins further expansion of its German plant.
19-Feb-2013 - Biocatalysis is emerging as a hot topic for CMOs in 2013 with AMRI, Almac and DSM all citing drug industry demand as the driver for recent collaborations.
19-Feb-2013 - In its second announcement of a closing research unit in little more than a week, Pfizer will axe its peptide therapeutic R&D unit CovX Research in San Diego, CA and...
19-Feb-2013 - Dow has contracted Cambrex to make its solubility enhancing polymer HPMCAS, adding manufacturing clout to its bioavailability-focused collaboration with Bend Research.
19-Feb-2013 - Takeda says it will help Nihon Pharmaceuticals bring manufacturing operations up to code after Japanese regulators order the CMO to halt production and recall one lot of its vitamin B1...
18-Feb-2013 - AMRI has predicted continuing revenue growth in its contract manufacturing with its API pipeline and once-troubled Burlington site leading the way.
18-Feb-2013 - CRL (Charles River Laboratories) saw a number of setbacks in the last quarter of 2012 but still expects growth in 2013.
18-Feb-2013 - Merck & Co and Lycera have signed a preclinical research deal that could be worth up to $300m if certain milestones are met.
18-Feb-2013 - Quintiles painted a rosy picture of the CRO sector in its much anticipated IPO, predicting that biopharma R&D spending will increase and demand for outsourced research will grow. ...
14-Feb-2013 - Hospira says bringing medical device manufacturing operations up to code will take 'a lot of work' after Lake Forest, Illinois plant is hit with US FDA Form 483.
14-Feb-2013 - SGS says the expansion of its Belgian unit will offer a new approach in its clinical trials involving smaller sample sizes.
14-Feb-2013 - Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry.
14-Feb-2013 - PPD has expanded its central lab testing services at its Brussels and Singapore labs and will offer additional services in microbiology, peripheral blood mononuclear cell and molecular pathology services.
13-Feb-2013 - Small biotech companies looking to crack into the increasingly lucrative Chinese pharma market need to outsource or partner with a local company in order to bring their products to market...
13-Feb-2013 - The US FDA has expedited approval of Jubilant HollisterStier manufacturing sites in further fallout from Ben Venue’s consent decree.
13-Feb-2013 - Bristol-Myers Squibb (B-MS) will continue to make the OTCs it licensed to Reckitt Benckiser for the time being but will hand over manufacturing if the UK drugmaker buys them outright.
12-Feb-2013 - Recipharm has penned a deal to supply the material for trials of a new drug designed to prevent side-effects in chemotherapy patients.
12-Feb-2013 - Rumours of a Quintiles IPO will not go away but as yet nothing has been confirmed.
12-Feb-2013 - Formulations of two ophthalmic drugs have become the first exports to Europe from Bangladeshi company Beximco as they seek to expand into the EU market.
12-Feb-2013 - Swedish CRO Trial Form Support has announced plans to make its second late-stage, IT focused acquisition in the space of three months.
11-Feb-2013 - More flexible regulations on the path for approving potential Alzheimer's disease treatments represent a huge opportunity, according to the US FDA, CROs and research advocates.
11-Feb-2013 - Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.
11-Feb-2013 - Bend Research says collaboration between the Swedish MPA and the US FDA was the reasoning in pursuing GMP from the European body.
11-Feb-2013 - As part of wider R&D cuts, Pfizer will close its clinical research unit in Singapore later this year and lay off about 30 employees.
07-Feb-2013 - Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Recipharm, Aesica and SMS Oncology.
07-Feb-2013 - Rexam says that expansion of its French plant is led by Lilly and the growing demand for insulin delivery products.
07-Feb-2013 - Proposed amendments to Indian clinical trial laws on compensation are confusing and potentially problematic for sponsors and CROs says ACRO.
07-Feb-2013 - QPS has acquired Florida-based trial site Miami Research Associates (MRA), adding first-in-man capacity to its US services offering.
06-Feb-2013 - GVK Bioscience has granted the US FDA further access to its clinical biomarker database following an extension of its license agreement.
06-Feb-2013 - Almac says that FDA approval of its commercial packaging plant will open doors to fulfill demand from the US market.
06-Feb-2013 - CROs invest in scope and scale while private-equity groups buy firms they can expand according to Fairmount Partners’ managing director, Neal McCarthy.
06-Feb-2013 - A storm is brewing over the release of clinical trial data as GlaxoSmithKline on Tuesday took a step away from UK and US industry groups and said it intends to...
05-Feb-2013 - Lonza has reorganised its operations into two new divisions – Pharma and Specialty ingredients – and says more changes are on the way.
05-Feb-2013 - CMOs and CROs must notify sponsors of payments made to physicians on their behalf under long-awaited US 'Sunshine' rules published last week.
05-Feb-2013 - Clinical trials made public by Pfizer did not match internal reports or reflect what was done in studies of the seizure drug gabapentin say researchers calling for revision of journal...
05-Feb-2013 - Icon has agreed to purchase the clinical trials services division of Cross Country Healthcare for $52m to primarily expand its staffing, pharmacovigilance and drug safety services.
04-Feb-2013 - Patheon says expanding its UK facility is necessary in offering its Solupath services to a European and Asian market.
04-Feb-2013 - The Consent decree was a necessary response to Ben Venue's long history of quality failures says the US FDA.
04-Feb-2013 - Solvias has bought quality control services firm Confarma, expanding its analytical offering and adding capacity in several EU markets.
|« Previous month||Next month »|